INSIGHTS ON QUALITY CONTROL

  • Scientific Data Is Not AI‑Ready By Default
    6/26/2026

    Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.

  • Why Cloud Migration Is The Key To Business Agility
    5/31/2026

    Discover how transitioning to cloud-native architectures drives business agility in biopharma, reducing infrastructure costs, minimizing downtime, and accelerating time to market for novel therapies.

  • Capsule Checkweigher Weigh Cell
    6/16/2026

    Examine these internal component updates and see how modular scaling optimizes mass-inspection tasks. Achieve consistent weight accuracy on high-speed pharmaceutical lines with this checkweigher.

  • Ask Us Anything: Hannah McLachlan on Crystallization In Peptide Development
    7/24/2026

    Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.

  • Building R&D Knowledge Into GMP Documentation
    6/1/2026

    Integrating R&D knowledge into GMP documentation ensures consistent aseptic powder fill‑finish processes by capturing material insights, defining controls, and enabling reliable, knowledge‑driven manufacturing.

QUALITY CONTROL SOLUTIONS

  • See how automated microbial quality control reduces manual handling, accelerates growth detection, and preserves colonies for identification while supporting faster manufacturing decisions.

  • Active bead release gives manufacturers precise control over T cell isolation timing, phenotype preservation, and workflow efficiency, eliminating multi-day passive dissociation delays.

  • Ensure operator safety and product purity with unidirectional airflow solutions. Explore how modular ISO 5 environments provide containment and cross-contamination control for critical processes.

  • Explore an extensive analytical chemistry and microbial testing compliant portfolio for pharmaceutical analysis and quality control (QC) from early-stage drug development to product release.

  • Traditional bioburden testing (or microbial limit testing) takes several days to grow visible colonies of microorganisms, so identifying these and initiating corrective action takes longer. The Milliflex® Quantum system quantitatively detects microbial contamination in filterable samples in as little as a third of the time it takes with traditional plate-based monitoring methods. The Milliflex® Quantum system is based on fluorescent staining of all viable microorganisms, making emerging microcolonies visible to the system when they’re still too small to be seen with the naked eye. After rapid detection, the colonies can be reincubated to grow into visible colonies and be identified by any method—an approach that cleverly combines rapid and compendial bioburden testing.